Voyager Therapeutics, Inc. Debt Securities, Available-for-sale
Voyager Therapeutics, Inc. (VYGR) had Debt Securities, Available-for-sale of $43.71 million as of 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2021-05-10
- 2021-03-31: Debt Securities, Available-for-sale $43.71M.
- 2020-12-31: Debt Securities, Available-for-sale $76.70M.
- 2020-09-30: Debt Securities, Available-for-sale $54.76M.
- 2020-06-30: Debt Securities, Available-for-sale $86.77M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2021-03-31 | $43.71M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $76.70M 10-Q · filed 2021-05-10 |
| 2020-09-30 | $54.76M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $86.77M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $87.14M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $197.41M 10-K · filed 2021-02-25 |
| 2019-09-30 | $226.78M 10-Q · filed 2019-11-06 |
| 2018-12-31 | $109.58M 10-K · filed 2020-03-03 |
| 2017-12-31 | $138.62M 10-K · filed 2018-03-14 |
| 2017-09-30 | $77.39M 10-Q · filed 2017-11-02 |
| 2016-12-31 | $137.78M 10-K · filed 2018-03-14 |
| 2015-12-31 | $193.04M 10-K · filed 2016-03-17 |
| 2015-09-30 | $94.06M 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |